Innovator International Developed Power Buffer ETF - November - INOV STOCK NEWS

Inovalon reported Q2 2020 financials with revenue of $162.2 million, up 3% YoY. Subscription revenue reached $142.1 million, a 13% increase, constituting 88% of total revenue. Net income was $2.0 million ($0.01 per share), while Non-GAAP net income rose 15% to $22.0 million ($0.15 per share). Adjusted EBITDA increased by 8% to $56.6 million with an Adjusted EBITDA margin of 34.9%. The company improved its cash balance to $95.6 million after repaying $99 million of debt, while record new sales ACV hit $75.7 million.

Inovalon (Nasdaq: INOV) announced a long-term partnership with Walmart's Specialty Pharmacy to enhance healthcare outcomes via the Inovalon ONE® Platform. This collaboration leverages the ScriptMed® Cloud technology, aimed at optimizing specialty pharmacy operations by automating processes and providing data-driven insights. By utilizing this cloud-based solution, Walmart will improve medication dispensing efficiency, reduce costs, and enhance patient care quality across its extensive pharmacy network. The partnership highlights Inovalon's role in supporting Walmart’s mission of delivering patient-centric, cost-effective healthcare.

Inovalon (Nasdaq: INOV) has announced a conference call for investors on July 29, 2020, at 5:00 p.m. Eastern Time. The call will discuss the highlights of the Company's second quarter 2020 financial results, which will be released following market close on the same day. Investors can join the call by dialing the provided phone numbers and access a replay afterward on Inovalon's website. Inovalon is noted for its cloud-based platforms enhancing data-driven healthcare.

Inovalon (Nasdaq: INOV) announced a five-year partnership with Cardinal Health (NYSE: CAH) to implement ScriptMed® Cloud for its durable medical equipment (DME) and medical supplies business. The DME market is projected to grow from $49 billion in 2019 to over $79 billion by 2027 due to the increasing elderly and chronically ill population. This collaboration aims to enhance operational efficiency and patient care quality while adapting to complex healthcare needs.

Inovalon (Nasdaq: INOV) has entered a multi-year partnership with Priority Health, a Michigan health plan, to implement its Inovalon ONE® Platform. This initiative aims to enhance member insights and economic performance for both commercial and Medicare Advantage memberships. The platform will replace an existing solution, enabling integrated healthcare connectivity and advanced analytics to improve member care outcomes and reporting. Implementation is set to begin in the second half of 2020, leveraging Inovalon’s extensive medical data registry to support Priority Health’s commitment to quality healthcare.

Inovalon (Nasdaq: INOV) announced that its 2020 annual stockholder meeting will be held virtually on June 17, 2020, at 10:00 a.m. ET, due to COVID-19 health concerns and restrictions. Stockholders can vote via existing proxy cards without needing new ones, and are encouraged to participate in the meeting by registering by June 14, 2020. The meeting's agenda remains unchanged, as detailed in prior filings with the SEC. Inovalon provides cloud-based healthcare solutions that aggregate data for improved healthcare outcomes and supports numerous healthcare organizations across the U.S.

Inovalon (Nasdaq: INOV) has launched InfectionWatch™, a cloud-based infection surveillance solution, aimed at healthcare facilities to improve the identification of antibiotic-resistant infections and virus outbreaks like COVID-19. This tool assists facilities in meeting CMS regulatory compliance and enhances quality outcomes. InfectionWatch™ leverages real-time EHR data and predictive analytics to track infection trends, monitor healthcare-acquired infections (HAIs), and recommend prevention interventions. The launch is timely, responding to increased demand in the healthcare market for effective infection control.

Inovalon (Nasdaq: INOV) has launched the Consumer Health Gateway™, a FHIR®-based module of the Inovalon ONE® Platform. This initiative facilitates health plans’ compliance with the 21st Century Cures Act, effective July 1, 2021, by allowing real-time patient data access. With an estimated compliance cost of $2 million for health plans, the gateway is designed to enhance healthcare consumerism by enabling third-party applications that utilize personal healthcare data. Inovalon supports 24 of the top 25 U.S. health plans, positioning itself as a leader in healthcare interoperability.

Inovalon (Nasdaq: INOV) announced participation in a fireside chat at the SunTrust Robinson Humphrey Virtual Meeting on May 22, 2020, at 1:00 PM ET. The chat will feature CEO Keith Dunleavy and CFO Jonathan R. Boldt, who will share insights into the company's data-driven healthcare platform. Investors can access the live and archived session via a provided link. Inovalon's cloud-based platform connects healthcare data, improving care efficiency and financial performance for clients, including top health plans and pharma companies.